S&P 500   4,002.87
DOW   32,560.60
QQQ   310.34
Game-Changing News For Tesla Investors 
Buy THIS stock before Taiwan is attacked (Ad)
These 3 Stocks Are Ready To Rally Out Of Bullish Bases
Microsoft Is The New Safe Haven
Buy THIS stock before Taiwan is attacked (Ad)
These Are The Top 3 Large Caps For Yield And Dividend Growth 
A Guy Is Using ChatGPT to Turn $100 Into a Business Making as Much Money as Possible. Here Are the First 4 Steps the AI Chatbot Gave Him.
Buy THIS stock before Taiwan is attacked (Ad)
DOW New Hghs Coming Sooner Than Later
Will Advanced Micro Devices Follow NVIDIA Higher? 
S&P 500   4,002.87
DOW   32,560.60
QQQ   310.34
Game-Changing News For Tesla Investors 
Buy THIS stock before Taiwan is attacked (Ad)
These 3 Stocks Are Ready To Rally Out Of Bullish Bases
Microsoft Is The New Safe Haven
Buy THIS stock before Taiwan is attacked (Ad)
These Are The Top 3 Large Caps For Yield And Dividend Growth 
A Guy Is Using ChatGPT to Turn $100 Into a Business Making as Much Money as Possible. Here Are the First 4 Steps the AI Chatbot Gave Him.
Buy THIS stock before Taiwan is attacked (Ad)
DOW New Hghs Coming Sooner Than Later
Will Advanced Micro Devices Follow NVIDIA Higher? 
S&P 500   4,002.87
DOW   32,560.60
QQQ   310.34
Game-Changing News For Tesla Investors 
Buy THIS stock before Taiwan is attacked (Ad)
These 3 Stocks Are Ready To Rally Out Of Bullish Bases
Microsoft Is The New Safe Haven
Buy THIS stock before Taiwan is attacked (Ad)
These Are The Top 3 Large Caps For Yield And Dividend Growth 
A Guy Is Using ChatGPT to Turn $100 Into a Business Making as Much Money as Possible. Here Are the First 4 Steps the AI Chatbot Gave Him.
Buy THIS stock before Taiwan is attacked (Ad)
DOW New Hghs Coming Sooner Than Later
Will Advanced Micro Devices Follow NVIDIA Higher? 
S&P 500   4,002.87
DOW   32,560.60
QQQ   310.34
Game-Changing News For Tesla Investors 
Buy THIS stock before Taiwan is attacked (Ad)
These 3 Stocks Are Ready To Rally Out Of Bullish Bases
Microsoft Is The New Safe Haven
Buy THIS stock before Taiwan is attacked (Ad)
These Are The Top 3 Large Caps For Yield And Dividend Growth 
A Guy Is Using ChatGPT to Turn $100 Into a Business Making as Much Money as Possible. Here Are the First 4 Steps the AI Chatbot Gave Him.
Buy THIS stock before Taiwan is attacked (Ad)
DOW New Hghs Coming Sooner Than Later
Will Advanced Micro Devices Follow NVIDIA Higher? 
NASDAQ:NVNO

enVVeno Medical - NVNO Stock Forecast, Price & News

$5.01
+0.10 (+2.04%)
(As of 03/21/2023 12:00 AM ET)
Add
Compare
Today's Range
$4.95
$5.05
50-Day Range
$4.71
$6.30
52-Week Range
$3.35
$7.93
Volume
8,147 shs
Average Volume
18,859 shs
Market Capitalization
$47.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

NVNO stock logo

About enVVeno Medical (NASDAQ:NVNO) Stock

enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company’s lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI). Deep venous CVI occurs when valves inside of the deep veins of the leg become damaged, resulting in insufficient blood being returned to the heart. The malfunctioning vein valves cause blood to flow backwards (reflux) and pool in the lower leg, increasing the pressure within the veins of the leg (venous hypertension). In the most severe cases, CVI can lead to venous ulcers (open skin sores) that become chronic and difficult to heal. The VenoValve is implanted in the femoral vein and works as a replacement venous valve, designed to reduce reflux and venous hypertension, and to restore proper directional blood flow back to the heart. With severe deep venous CVI impacting an estimated 2.4 million people in the U.S., who have no effective treatment options, the VenoValve has received Breakthrough Device Designation from the U.S. Food and Drug Administration, and is currently being evaluated in the SAVVE U.S. clinical trial.

Receive NVNO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for enVVeno Medical and its competitors with MarketBeat's FREE daily newsletter.

NVNO Stock News Headlines

The Stock That Is Flying Under Wall St. Radar
With The Founder OF XPO Logistics Leading The Way This Nasdaq Company is Ready and GOING!pixel
The Stock That Is Flying Under Wall St. Radar
With The Founder OF XPO Logistics Leading The Way This Nasdaq Company is Ready and GOING!pixel
NVNO enVVeno Medical Corporation
enVVeno Medical Corp
See More Headlines
Receive NVNO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for enVVeno Medical and its competitors with MarketBeat's FREE daily newsletter.

NVNO Company Calendar

Last Earnings
8/11/2021
Today
3/22/2023
Next Earnings (Estimated)
3/27/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:NVNO
Employees
19
Year Founded
N/A

Profitability

Net Income
$-24,670,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$4.09 per share

Miscellaneous

Free Float
7,928,000
Market Cap
$47.44 million
Optionable
Not Optionable
Beta
1.27

Key Executives

  • Robert Andrew BermanRobert Andrew Berman
    Chief Executive Officer & Director
  • Craig T. Glynn
    Chief Financial Officer & Treasurer
  • Marc H. GlickmanMarc H. Glickman
    Chief Medical Officer & Senior Vice President
  • Hamed Alavi
    Vice President-Research, Development & Quality













NVNO Stock - Frequently Asked Questions

How have NVNO shares performed in 2023?

enVVeno Medical's stock was trading at $5.10 at the start of the year. Since then, NVNO stock has decreased by 1.8% and is now trading at $5.01.
View the best growth stocks for 2023 here
.

When is enVVeno Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, March 27th 2023.
View our NVNO earnings forecast
.

How were enVVeno Medical's earnings last quarter?

enVVeno Medical Corporation (NASDAQ:NVNO) released its quarterly earnings results on Wednesday, August, 11th. The company reported ($0.28) EPS for the quarter, topping analysts' consensus estimates of ($0.34) by $0.06.

What is enVVeno Medical's stock symbol?

enVVeno Medical trades on the NASDAQ under the ticker symbol "NVNO."

Who are enVVeno Medical's major shareholders?

enVVeno Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Morgan Stanley (0.32%). Insiders that own company stock include Francis Duhay, Gmt Capital Corp, Holding SA Biodyne, Marc H Glickman, Matthew Jenusaitis, Robert Andrew Berman, Robert Gray and Sanjay Shrivastava.
View institutional ownership trends
.

How do I buy shares of enVVeno Medical?

Shares of NVNO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is enVVeno Medical's stock price today?

One share of NVNO stock can currently be purchased for approximately $5.01.

How much money does enVVeno Medical make?

enVVeno Medical (NASDAQ:NVNO) has a market capitalization of $47.44 million. The company earns $-24,670,000.00 in net income (profit) each year or ($2.58) on an earnings per share basis.

How can I contact enVVeno Medical?

enVVeno Medical's mailing address is 70 DOPPLER, IRVINE CA, 92618. The official website for the company is www.hancockjaffe.com. The company can be reached via phone at (949) 261-2900 or via fax at 949-261-2992.

This page (NASDAQ:NVNO) was last updated on 3/22/2023 by MarketBeat.com Staff